These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37929881)

  • 21. Long-term biochemical recurrence rates after robot-assisted radical prostatectomy: analysis of a single-center series of patients with a minimum follow-up of 5 years.
    Suardi N; Ficarra V; Willemsen P; De Wil P; Gallina A; De Naeyer G; Schatteman P; Montorsi F; Carpentier P; Mottrie A
    Urology; 2012 Jan; 79(1):133-8. PubMed ID: 22088567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Event-free survival after radical prostatectomy according to prostate-specific membrane antigen-positron emission tomography and European Association of Urology biochemical recurrence risk groups.
    Roberts MJ; Chatfield MD; Hruby G; Nandurkar R; Roach P; Watts JA; Cusick T; Kneebone A; Eade T; Ho B; Nguyen A; Tang C; McCarthy M; Francis R; Stricker P; Emmett L
    BJU Int; 2022 Nov; 130 Suppl 3(Suppl 3):32-39. PubMed ID: 35488182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Higher rates of upgrading and upstaging in older patients undergoing radical prostatectomy and qualifying for active surveillance.
    Busch J; Magheli A; Leva N; Ferrari M; Kramer J; Klopf C; Kempkensteffen C; Miller K; Brooks JD; Gonzalgo ML
    BJU Int; 2014 Oct; 114(4):517-21. PubMed ID: 24112652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salvage Radical Prostatectomy for Recurrent Prostate Cancer Following First-line Nonsurgical Treatment: Validation of the European Association of Urology Criteria in a Large, Multicenter, Contemporary Cohort.
    Calleris G; Marra G; Benfant N; Rajwa P; Ahmed M; Abreu A; Cacciamani G; Ghoreifi A; Ribeiro L; Westhofen T; Tourinho-Barbosa R; Raskin Y; Veerman H; Albisinni S; Smith JA; Rouprêt M; Oderda M; Massari E; Persad R; Van Der Poel H; Joniau S; Sanchez-Salas R; Kretschmer A; Cathcart P; Gill I; Karnes RJ; Tilki D; Shariat SF; Touijer K; Gontero P
    Eur Urol Focus; 2023 Jul; 9(4):645-649. PubMed ID: 36682962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term oncological and continence outcomes after laparoscopic radical prostatectomy: a single-centre experience.
    Busch J; Stephan C; Herold A; Erber B; Kempkensteffen C; Hinz S; Lein M; Weikert S; Miller K; Magheli A
    BJU Int; 2012 Dec; 110(11 Pt C):E985-90. PubMed ID: 22672442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advancing Age and the Odds of Upgrading and Upstaging at Radical Prostatectomy in Men with Gleason Score 6 Prostate Cancer.
    Leeman JE; Chen MH; Huland H; Graefen M; D'Amico AV; Tilki D
    Clin Genitourin Cancer; 2019 Dec; 17(6):e1116-e1121. PubMed ID: 31601512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term cancer control outcomes in patients with clinically high-risk prostate cancer treated with robot-assisted radical prostatectomy: results from a multi-institutional study of 1100 patients.
    Abdollah F; Sood A; Sammon JD; Hsu L; Beyer B; Moschini M; Gandaglia G; Rogers CG; Haese A; Montorsi F; Graefen M; Briganti A; Menon M
    Eur Urol; 2015 Sep; 68(3):497-505. PubMed ID: 26119559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemical outcomes after robot-assisted radical prostatectomy in patients with follow-up more than 5-years.
    Kim KH; Lim SK; Shin TY; Chung BH; Hong SJ; Rha KH
    Asian J Androl; 2013 May; 15(3):404-8. PubMed ID: 23524532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Robotic radical prostatectomy as the initial step in multimodal therapy for men with high-risk localised prostate cancer: initial experience of 160 men.
    Connolly SS; Cathcart PJ; Gilmore P; Kerger M; Crowe H; Peters JS; Murphy DG; Costello AJ
    BJU Int; 2012 Mar; 109(5):752-9. PubMed ID: 21992472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laparoscopic versus robot-assisted bilateral nerve-sparing radical prostatectomy: comparison of pentafecta rates for a single surgeon.
    Asimakopoulos AD; Miano R; Di Lorenzo N; Spera E; Vespasiani G; Mugnier C
    Surg Endosc; 2013 Nov; 27(11):4297-304. PubMed ID: 23807752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Robotic radical prostatectomy: analysis of midterm pathologic and oncologic outcomes: A historical series from a high-volume center.
    Asimakopoulos AD; Annino F; Mugnier C; Lopez L; Hoepffner JL; Gaston R; Piechaud T
    Surg Endosc; 2021 Dec; 35(12):6731-6745. PubMed ID: 33289056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of pathological upstaging or upgrading on metastasis and cancer-specific mortality in men with clinical low-risk prostate cancer.
    Kovac E; Vertosick EA; Sjoberg DD; Vickers AJ; Stephenson AJ
    BJU Int; 2018 Dec; 122(6):1003-1009. PubMed ID: 29802773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3 + 4 = 7 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsy.
    Keefe DT; Schieda N; El Hallani S; Breau RH; Morash C; Robertson SJ; Mai KT; Belanger EC; Flood TA
    Virchows Arch; 2015 Oct; 467(4):437-42. PubMed ID: 26229020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of the European association of urology biochemical recurrence risk groups after radical prostatectomy in an Asian cohort and suggestions for refinement.
    Pak S; Lee DE; You D; Jeong IG; Joung JY; Lee KH; Hong JH; Kim CS; Ahn H
    Urol Oncol; 2021 May; 39(5):298.e1-298.e6. PubMed ID: 33579626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined multiple clinical characteristics for prediction of discordance in grade and stage in prostate cancer patients undergoing systematic biopsy and radical prostatectomy.
    Liu H; Tang K; Xia D; Peng E; Wang L; Chen Z
    Pathol Res Pract; 2020 Nov; 216(11):153235. PubMed ID: 33035728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of prostate-specific antigen recurrence-free survival in a contemporary cohort of patients undergoing either radical retropubic or robot-assisted laparoscopic radical prostatectomy.
    Schroeck FR; Sun L; Freedland SJ; Albala DM; Mouraviev V; Polascik TJ; Moul JW
    BJU Int; 2008 Jul; 102(1):28-32. PubMed ID: 18384634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparisons of the perioperative, functional, and oncologic outcomes after robot-assisted versus pure extraperitoneal laparoscopic radical prostatectomy.
    Ploussard G; de la Taille A; Moulin M; Vordos D; Hoznek A; Abbou CC; Salomon L
    Eur Urol; 2014 Mar; 65(3):610-9. PubMed ID: 23245815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy.
    Smith JA; Chan RC; Chang SS; Herrell SD; Clark PE; Baumgartner R; Cookson MS
    J Urol; 2007 Dec; 178(6):2385-9; discussion 2389-90. PubMed ID: 17936849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Learning curve of minimally invasive radical prostatectomy: Comprehensive evaluation and cumulative summation analysis of oncological outcomes.
    Sivaraman A; Sanchez-Salas R; Prapotnich D; Yu K; Olivier F; Secin FP; Barret E; Galiano M; Rozet F; Cathelineau X
    Urol Oncol; 2017 Apr; 35(4):149.e1-149.e6. PubMed ID: 28117215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic Consequences of Omitting a Pelvic Lymph Node Dissection at Radical Prostatectomy when Grade and/or Stage Increase.
    Altok M; Chapin BF; Matin SF; Achim MF; Gregg JR; Davis JW
    Urology; 2021 Sep; 155():144-151. PubMed ID: 33676955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.